--- title: "Anthropic sell-side briefing: key disclosures; is expectations mgmt underway?" type: "Topics" locale: "en" url: "https://longbridge.com/en/dolphin/post/44975810.md" description: "On Nov 10, two sell-side analysts from $Anthropic(ANT.US)'s IPO syndicate (one covering software, one internet) hosted a Q&A. Although some key figures were their own estimates, the timing suggests a degree of management endorsement, making it a useful read-through for Anthropic's near- to mid-term growth outlook. Dolphin Research's takeaway: soft near term but more upbeat over the medium to long run (vs. already-trimmed expectations), underscoring a company with bold monetization ambitions." datetime: "2026-11-11T12:13:26.000Z" locales: - [en](https://longbridge.com/en/dolphin/post/44975810.md) - [zh-CN](https://longbridge.com/zh-CN/dolphin/post/44975810.md) - [zh-HK](https://longbridge.com/zh-HK/dolphin/post/44975810.md) author: "[Dolphin Research](https://longbridge.com/en/dolphin.md)" generator: "portal-rs" --- # Anthropic sell-side briefing: key disclosures; is expectations mgmt underway? On Nov. 10, two sell-side analysts from the IPO syndicate covering software and internet hosted a Q&A on $Anthropic(ANT.US). While some headline numbers reflect their estimates, the timing suggests management likely gave partial validation. This is meaningful for our near- to mid-term growth view on Anthropic. **Dolphin Research take:** near-term outlook is soft, but medium to long term remains constructive relative to already-lowered expectations. The company is ambitious on monetization, prioritizing 1P compute build-out and using heavy training spend to raise competitive barriers. Details below. We break it down. **1) Key numbers first.** See the snapshot. **2) Key takeaways.** Highlights follow. **1) Q4 looks soft, with three drivers.** Details below. (1) Holiday seasonality; (2) distillation revenue goes to zero for the full Q4; (3) price cuts — revenue per account dips after switching to new models, then normalizes in ~two weeks. Management downplayed the impact from META and MSFT usage cuts, which is at odds with prior reporting; we think the drag is likely non-trivial. Opus 5.5 is priced 40% lower vs. Opus 5. To keep revenue flat, tokens must expand by ~67%. **Distillation revenue (about 10% in Jul) is a one-off headwind, but price cuts are structural.** The reverse gap between a Q4 annualized run-rate of 77.2 bn vs. Oct ARR of 81.0 bn underscores why high-frequency monthly ARR is not a solid valuation anchor for Anthropic. Near-term volatility makes simple extrapolation risky. The first public guide (Q4'26) already sits below the annualized run-rate. Expect additional pricing pressure into 1H next year as newer models roll through. Pushing a more optimistic linear extrapolation on existing high-frequency ARR effectively layers a second derivative on top of a second derivative, doubling whipsaw risk. That helps explain the swinging valuation narratives — from 0.9 tn to 2 tn, back to 1 tn, and now a hot bookbuilding trying to lift to 1.5 tn — all without a firm anchor. **2) Monetization expectations for next year are not low, with growth leaning on user penetration.** This is more about adding customers than simply driving token consumption. Street expects a quarterly annualized revenue of ~185 bn; if delivered, year-end ARR likely tops 200 bn. That is well above our neutral 150 bn case, and the hosting analysts are openly guiding toward ~200 bn. Momentum assumptions are clearly optimistic. **Given steep token price cuts, the path is volume-led — not by tokens, but by new customers.** The underwriters’ model assumes ~5,000 new enterprise customers next year, modest ARPC uplift, big accounts spending $2–3 mn each, plus ~100k accounts converting to paid upgrades. The AI4S verticals (e.g., life sciences) in the prospectus remain early; industry checks suggest limited signed deals so far. We are skeptical on the math. Even if all 5,000 were large accounts at the indicated spend, the incremental would be just a bit over 10 bn, which seems inconsistent with the topline target. **3) Emphasis shifts to compute efficiency, with continued heavy spend to widen the gap.** The message to investors: focus on efficiency (revenue/compute spend), not raw GW. Management acknowledged over-committing to capacity ahead of demand to avoid over-reliance on SpaceX’s high-priced compute. Media reports point to ~3.5 GW in operation and 4.67 GW contracted for 2026, so translating capacity plans directly into revenue could overstate near-term monetization. The efficiency framing also aligns with an expected turn to negative Adj. margins in 2027. The company has signed ~620 bn of cloud compute commitments (CSPs, SpaceX, and other new clouds). Going forward, it will prioritize 1P compute via a multi-chip plus direct procurement strategy, building owned data centers to compress intermediary margins. This should help cost control over time. **In a fierce race, Anthropic may keep swinging big.** Training compute in 2027 is guided at about $90 bn, roughly 3.4x 2026, to widen the lead versus followers. If the current 8:2 train:infer ratio holds, total compute spend next year implies around $120 bn. That lines up with the ~120 bn of 2027 compute commitments already signed (see our annual allocation view below). However, any upside surprise in inference demand would require either a higher train:infer mix or fresh compute contracts, as owned data centers likely will not ramp that fast. **We see an expected consequence — profits likely fall sharply next year.** Adj. OPM was 14.5% in Q3'26, but with compute spend north of $120 bn in 2027, Non-GAAP OPM turning negative for the full year looks almost inevitable. Investors should brace for margin compression. At a 1.2 tn IPO (market talk ranges 1.0–1.5 tn), this implies ~10x next-year P/S and sub-8x P/ending ARR. Rich or cheap will depend on longer-dated scenarios and more conservative assumptions. A wider distribution of outcomes argues for prudent framing. **We will publish more on Anthropic’s valuation shortly — comments welcome.** Near-term metrics to watch that could move both estimates and multiples include Fable 5.2 performance post-launch, actual Q4 revenue, and the pricing trajectory for next-gen models (several are in the queue). Stay tuned. \ Risk disclosure and statement: [Dolphin Research disclaimer and general disclosures](https://support.longbridge.global/topics/misc/dolphin-disclaimer). Please review before making investment decisions. **Dolphin Research coverage history on Anthropic:** Selected prior notes below. Oct. 27, 2026 initial coverage, Part I: [Anthropic: From cash-burner to compute landlord — the trillion-dollar march is long](https://longbridge.com/en/dolphin/post/44562870?channel=OWNN00030). ### Related Stocks - [ANT.US](https://longbridge.com/en/quote/ANT.US.md) - [META.US](https://longbridge.com/en/quote/META.US.md) - [MSFT.US](https://longbridge.com/en/quote/MSFT.US.md) - [SPCX.US](https://longbridge.com/en/quote/SPCX.US.md) - [METAM.US](https://longbridge.com/en/quote/METAM.US.md) - [UXSD.SG](https://longbridge.com/en/quote/UXSD.SG.md) ## Comments (3) - **MaxSureWin · 2026-11-13T00:30:16.000Z**: everyone buying Nvidia? - **FreeBuild · 2026-11-12T00:27:57.000Z**: thanks - **Dolphin fans** (2026-11-12T03:47:01.000Z): Welcome👏👏👏 --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**